Biomotion Sciences Ordinary Shares (SLXN) — Capital Reinvestment Ratio
Latest as of December 2022:
0.00x
Biomotion Sciences Ordinary Shares (SLXN) has a Capital Reinvestment Ratio of 0.00x as of December 2022, meaning it reinvests 0% of its operating cash flow ($660.30K) in capital expenditures ($3.00). Check Biomotion Sciences Ordinary Shares tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$660.30K
USD
Capital Expenditures
$3.00
USD
Data as of
Dec 2022
Most recent filing
Annual Capital Reinvestment Ratio for Biomotion Sciences Ordinary Shares (None–None)
Year-by-year Capital Reinvestment Ratio for Biomotion Sciences Ordinary Shares from None to None. See Biomotion Sciences Ordinary Shares free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow